Genmab | GEN - Trade Debtors



Genmab reported DKK998M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Agios Pharmaceuticals USD 4.99M 1.64M Jun/2025
Almirall EUR 193.8M 20.72M Jun/2025
Amarin USD 106.73M 15.54M Mar/2025
Amgen USD 8.7B 569M Jun/2025
argenx SE 1.2B 289.13M Jun/2025
AstraZeneca USD 16.24B 1.42B Jun/2025
Bayer EUR 17.64B 895M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Demant DKK 5.24B 790M Jun/2025
Exelixis USD 292.35M 10.72M Jul/2025
Fresenius Medical Care EUR 3.23B 333.55M Jun/2025
Galapagos EUR 223.52M 140.03M Jun/2025
Genmab DKK 998M 199M Jun/2025
GlaxoSmithKline GBP 7.7B 196M Jun/2025
GN Store Nord DKK 5.97B 443M Jun/2025
GRIFOLS EUR 1.25B 213.13M Jun/2025
Hikma Pharmaceutical USD 973M 8M Dec/2024
Insmed USD 55.03M 7.29M Jun/2025
Lonza CHF 1.33B 269M Dec/2024
Merck EUR 4.92B 62M Jun/2025
Novartis USD 9.18B 451M Jun/2025
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
Sanofi 8.21B 7.76B Jun/2025
UCB EUR 1.58B 157M Dec/2024